Insulin glulisine Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Drugs used in diabetes | Endocrine System
Items (12m)
10
Total Quantity
100
NHS Cost
£566
vs National Avg
-53.4%
MAPLE ACCESS PARTNERSHIP LLP prescribed 10 items of Insulin glulisine over the last 12 months at a cost of £566 to the NHS. This is 53.4% below the national average prescribing rate. Insulin glulisine is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
No monthly data available.
Prescribing Details
| Total Items | 10 |
|---|---|
| Total Quantity | 100 |
| Total NHS Cost | £566 |
| Presentations | 1 different forms |
| vs National Average | -53.4% |
Insulin glulisine Prescribing Comparison
| This practice | 10 items |
|---|---|
| National average per practice | 21 items |
| Difference | -53.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.